Project
This page asks whether the disease story changes once raw condition counts are translated into adjusted excess and ghost watchlists. It does.
The condition story splits into count-heavy disease portfolios and a separate healthy-volunteer silence pattern that is much more ghosted than merely overdue.
A standalone E156 project on which therapeutic portfolios still carry excess hiddenness once the series shifts from raw rates to adjusted condition-family watchlists.
Across The Series
The split projects are meant to be read together because each isolates a different dimension of registry opacity rather than forcing every question into one leaderboard.
Industry project from the CT.gov hiddenness series.
Sponsor-class project from the CT.gov hiddenness series.
Phase project from the CT.gov hiddenness series.
Structural missingness project from the CT.gov hiddenness series.
Evidence visibility project from the CT.gov hiddenness series.
Completion cohort project from the CT.gov hiddenness series.
Condition hiddenness project from the CT.gov hiddenness series.
Sponsor concentration project from the CT.gov hiddenness series.
Rule-era reporting project from the CT.gov hiddenness series.
Publication undercount audit from the CT.gov hiddenness series.
Oncology hiddenness project from the CT.gov hiddenness series.
Cardiovascular hiddenness project from the CT.gov hiddenness series.
Metabolic hiddenness project from the CT.gov hiddenness series.
Enrollment-size project from the CT.gov hiddenness series.
Geography-scale project from the CT.gov hiddenness series.
Design-purpose project from the CT.gov hiddenness series.
Completion-delay project from the CT.gov hiddenness series.
Trial-architecture project from the CT.gov hiddenness series.
Intervention-type project from the CT.gov hiddenness series.
Country reporting project from the CT.gov hiddenness series.
Stopped-trial project from the CT.gov hiddenness series.
Outcome-density project from the CT.gov hiddenness series.
Actual-field project from the CT.gov hiddenness series.
US-versus-global project from the CT.gov hiddenness series.
Modality-sponsor project from the CT.gov hiddenness series.
Country-condition project from the CT.gov hiddenness series.
Disease-geography project from the CT.gov hiddenness series.
Condition-sponsor project from the CT.gov hiddenness series.
Country-sponsor project from the CT.gov hiddenness series.
US-versus-ex-US project from the CT.gov hiddenness series.
Industry-family project from the CT.gov hiddenness series.
Risk-adjusted hiddenness from the CT.gov hiddenness series.
Overdue results clock from the CT.gov hiddenness series.
Publication index gap from the CT.gov hiddenness series.
Probable ACT/FDAAA debt from the CT.gov hiddenness series.
Sponsor-level adjusted watchlist showing which named sponsors still carry the largest excess hiddenness stock.
Country-linked adjusted watchlist showing which national portfolios remain worse than expected after visible study mix is held more constant.
A black-box audit of older studies with no results, no linked paper, and no detailed description.
Strict U.S.-nexus repeater tables showing which sponsors and classes dominate the regulated-looking backlog.